Alzprotect is a pharmaceutical company specialized in developing potential drugs, ranging from initial discovery to clinical trials, for the management of neurodegenerative disorders such as Alzheimer's disease (AD) and tauopathies like Progressive Supranuclear Palsy (PSP). The company has acquired exceptional expertise in tauopathies, where the degeneration of neurons is a result of the abnormal accumulation of the hyperphosphorylated Tau protein along with neuroinflammation in conditions such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease (AD).
Alzprotect
Headquarters
France